Publications by authors named "Noriaki Simada"
Article Synopsis
- The study aimed to evaluate the 6-year effectiveness of intravitreal bevacizumab (IVB) for treating choroidal neovascularization (CNV) caused by pathologic myopia in 36 eyes of 35 patients.
- Over the 6-year period, patients showed improvements in best-corrected visual acuity (BCVA) up to 4 years, but no significant improvement at 6 years compared to baseline, with a mean of 1.78 IVB treatments administered.
- The research identified that the BCVA after 6 years was significantly related to the size of CNV-related macular atrophy, highlighting the need for treatments that prevent macular atrophy for better long-term visual outcomes.
